Health Archive » July, 2019

Health - July, 2019

382 articles

• Ex-J&J Doctor Testifies She Told Bosses About Mesh Issues
• $17B Or Zilch? Okla., J&J Make Final Pitches After Opioid Trial
• Why Ariz. Is Taking Aim At The Sacklers At The High Court
• True Health Gets Nod For $7.8M DIP After Deadline Shift
• Ariz. Appeals Court Upholds Doc's Win In Faulty Surgery Suit
• PhRMA's New Attack On Calif. Drug Pricing Law Gets Traction
• Trump Birth Control Suit Halted To Appeal 3rd. Circ. Ruling
• Drug Distributor's Ex-CEO Faces May Trial Over Opioid Sales
• Mich. BCBS Stingy On Drug Treatment Payments, Suit Says
• Rosen Law To Lead Indivior Stock Suit Over Opioid Indictment
• Wilentz Goldman Strikes Deal After $1.5M Loss To Fired Atty
• Anthem Says Claims In $60M Benefits Suit Already Fell Flat
• Debunking 3 Myths About Contract Attorneys
• Takeaways From Enforcement Trends In Cannabis Advertising
• Arizona Files Supreme Court Lawsuit Over Opioid Crisis
• HHS Opens Door To Drug Imports Amid Shaky Pricing Efforts
• J&J 'Would Never Sell' Unsafe Talc, Rep Says In Ky. Trial
• Judge Told Taking Too Long To Rule In Texas Hospital Cases
• Eagles Guitarist's Widow Won't Give Up Info, Hospital Says
• Indian Health Service Names New Navajo Area Director
• Semenya Blocked From Running Amid Testosterone Appeal
• DC Circ. Gives Labs New Shot At Fighting Big Medicare Cuts
• Texas Opioid MDL Gets 2020 Trial Dates
• Diagnostic Firm Says Medicare Holdback Pushed It Into Ch. 11
• EEOC Roundup: 7 Things You May Have Missed
• Deals Rumor Mill: Sulaiman Al Habib, Lloyds, Diaverum
• Mylan Nears $30M Deal In SEC EpiPen Probe; CEO To Retire
• Premera Blue Cross' $32M Data Breach Deal Gets Green Light
• Ex-Trump Adviser Returns To Baker Donelson Via Alliance
• Asarco Retiree Class Gets Court OK In Health Benefits Fight
• Norton Healthcare Defends Early Retiree Benefit Methodology
• 4 Firms Rep Blank Check Co. New Frontier In China's UFH Buy
• PE Shop Collects $4.3B For Health Care, Tech Investments
• Fate Of CVS-Aetna Deal In The Hands Of Judge
• Texas Doc Says Kickback Law Too Vague, Demands New Trial
• J&J Lied In Mesh Marketing, Surgeon Tells Calif. Judge
• Hospitals, Insurers Lash Trump's Price-Transparency Demand
• Women Can Drop, Refile Warning Label Suit Over J&J Talc
• Generic Lamictal Buyers Defend Class Cert. At 3rd Circ.
• Seen This Before, Says Judge Blocking NH Medicaid Limit
• Pot Dispensary Chain Fires Back Over Ill. License Sale Suit
• Ill. Court Orders New Trial Over Hospital Rep's 'Vile' Letters
• Hospital System Beats Ex-Guard's PTSD Bias Suit At 6th Circ.
• CVS To Pay $15M For Unwanted Flu Shot Calls
• 3 Firms Steer $2.7B EQT, CPPIB Deal For Bain Health Pay Biz
• NY Pharmacist Cops To Role In 'Brazen' $5M Opioid Ring
• Rite Aid Investors Seek Cert. In Failed Walgreens Merger Suit
• Lawmakers Push Bill To Simplify Biosimilar Patent Fights
• Leaked Email In Price-Fixing Case Is Privileged, Heritage Says
• Class Certified In $891M Action Over Hospital Chain Fraud
• 'No Miscarriage Of Justice' In Insys Execs' Trial, Feds Say
• 3 Firms Lead $2.8B Merger Of Cancer Treatment Developers
• Law360 Reveals The Global 20 Firms Of 2019
• St. Jude Hit Humana With Faulty Pacemaker Costs, Suit Says
• Meet The Top Attys In Gilead's 'No Generics' Antitrust Rumble
• Mich. Doc Must Face Suit Over Patient's Bleeding Death
• Boston Scientific On Hook For $275M Merger, Chancery Told
• Eye Product Co. Says Feds' Attys Breached No-Contact Rule
• Law360's Tort Report: Personal Injury & Med Mal News In Brief
• Harvard Pilgrim, UBH Beat Boarding School Coverage Suit
• Philly Children's Hospital Ch. 11 Sale Plan Approved In Del.
• Ex-Lineman Tells 11th Circ. NFL Wrongly Denied Benefits
• Air Ambulance Co. Inks $5M Deal To End OT Case
• Compliance Imperatives For Defensible Data Disposal
• Pa. Grocery Chain Demands Insurer Cover Opioid Defense
• AGs Fire Back After Pharma Bid To End Price-Fixing Claims
• A Litigator's Reflections From The Arbitrator's Chair
• Health Hires: Epstein Becker, Morgan Lewis, Polsinelli
• Colgate, J&J Talc Contained No Asbestos, Geologist Tells Jury
• Florida Wants Redo On Ruling That Gutted Medical Pot Regs
• W.Va. Hospital Moves Audit Meddling Suit To Federal Court
• Marketing Co. Reaches $6.5M Insurance TCPA Deal
• Ky. Hospital Defeats ERISA Suit Over Church Plan Exemption
• AIG Can't Escape $236M Texas Medicaid Fraud Settlement
• New Trial Granted In Md. Cancer Patient's Misdiagnosis Suit
• Hospital Co. Reaches Tentative $127M FCA Deal With DOJ
• 8th Circ. Sides With WashU In Ex-Worker's Retaliation Suit
• Woman's Suit Against Hospital Over Son's Treatment Slashed
• Joerns Gets Nod For $320M Debt-Equity Swap Ch. 11 Plan
• Ill. Marijuana Dispensary Wants Out Of Deal To Sell License
• CMA Accuses Pharmas Of Divvying Market For UTI Treatment
• 5 Cos. Hit The Market With Combined $879M In IPOs
• 5 Hard Phrases Lawyers Should Master
• J&J Digs Into Methods Of Expert Who Found Asbestos In Talc
• Cherokee Nation Health Services Names New General Counsel
• Idaho Can't Dismiss Challenge To Doctor-Only Abortion Law
• Pa. Addiction Treatment Facility Inks $2.85M False Billing Deal
• Cities, Counties Lose Bid For Committee In Insys Ch. 11 Case
• Florida Justices Will Hear Botched 'Butt Lift' Case
• Injured Nurse Can't Be Expert In Own Case, Mass. Court Rules
• Allergan Recalls Cancer-Linked Textured Breast Implants
• Labs Ink $56M Deal To End UnitedHealthcare Kickback Claims
• OT Change Broke Labor Law, NLRB Judge Says
• Insights From Recent Cases Considering Waiver Of Privilege
• J&J Grills Marketing Expert Who Said It Hid Mesh Risks
• Insys GC To Leave Embattled Co. After Less Than A Year
• Med Mal Patient Hits Va. Damages Cap With $2.2M Verdict
• Texas Court Says Med Mal Expert's Report Is Deficient
• 3rd Circ. Says Board Observers Not Same As Directors
• Big Pharma Pounces On Bipartisan Drug Pricing Bill
• Trinity Sues Anesthesia Provider Over Noncompete Clauses
• FDA Must Reconsider Denial Of Braeburn Anti-Opioid Drug
• BCBS Unit Lands 8th Circ. Win In Air Ambulance ERISA Suit
• Immigration Attys, Filmmaker Sue Feds Over Surveillance
• Health Care Analytics Co. Raises IPO Target To $171.5M
• Insys Pulls Support For Novel Gov't Entities Committee
• Health Care REIT Lifts Australian Partnership To $3.4B
• Fed. Circ. Asked To Revive Parts Of Internal-Bleed Device IP
• Mass. Biotech Co. Liable For CEO Duping Investors, SEC Says
• Medical Properties Trust To Buy 8 UK Hospitals For $434M
• Philly Hospital Nurses Want Union Contract In Ch. 11 Sale
• Kirkland Leads DW Health Care Fund To $610M Close
• 16 States Back Ind. In Abortion Clinic Licensing Dispute
• Canadian Cannabis Producer Sundial Lights Up US IPO Plans
• White House, Congress Reach Bipartisan Budget Deal
• Calif. Expert Says J&J's 'Propaganda' Misled Mesh Patients
• DOJ Errors Doom Suboxone Film Fraud Case, Indivior Says
• Unlawful Pain Pill Sales Undeniable, Opioid MDL Counties Say
• House Dems, Others Assail Association Health Plan Rule
• Doc On Hook For $1M In Patient Privacy Breach Suit
• Fitbit, Garmin Stole Philips' Health Tracker Tech, Suits Allege
• Utah Supreme Court Strikes Down State Med Mal Law
• Pain Clinic, Tenn. State Senator Accused Of $25M Fraud
• Strong Debut Augurs Well For China's New Startup Market
• Third Amended Med Mal Suit Is Timely, Ill. Court Says
• Conn. Denies Leaking Heritage Doc In Generic-Drug Case
• Indian Hospitals Added To Indigenous Opioid Abuse, Feds Say
• Mount Sinai Begins $1B Downtown Health Care Revamp
• Livongo Ups Target For Wilson Sonsini-Led IPO To $267.5M
• Feds Must Hand Over Info In Eye Product Kickback Suit
• Trustee, MDL Group, Maryland AG Blast Insys Ch. 11 Proposal
• Ill. Court Reverses Clinic's Trial Win Over Fatal Blood Clot
• ABA Rips USPTO Attorney Fee Rule As 'Radical'
• Why Eliminating Surprise Medical Bills Is A Challenge
• Covington, Fried Frank Assist On $585M Deal For Dr. Scholl's
• E-Discovery Experts Could Increase Fed. Court Efficiency
• Texas Nurses Told To Go It Alone Or Drop Antitrust Suit
• Cancer Center Ch. 11 Reopened, But Not For Antitrust Fight
• BCBS Loses Bid To Toss Mental Health Coverage Class Action
• DOJ Tries To Push CVS-Aetna Deal Past Court Review
• Pa. Man's $3.5M Award Over Missed Heart Disease Upheld
• 'Everybody In The Crosshairs' As DOJ Opioid Blitz Gets Real
• Trump Admin's Short-Term Insurance Rule Survives Challenge
• 'Conspiracy' Claim Can't Save Antitrust Case, 7th Circ. Told
• Massachusetts Cases To Watch: Midyear Report
• Goodwin Guides Radiology Biz To $4B Valuation
• Philly Hospital's Ch.11 Plan To Sell Residency Program OK'd
• 11 Firms To Guide 7 IPOs Exceeding $1.4B As July Stays Hot
• Excela Surgical Center Doesn't Get Hospital's Tax Exemption
• Justice Stevens' Most Important Personal Injury Opinions
• 4 Arrested Over $10M Medicaid Fraud Via NYC Pharmacy
• 4 Things FTC Competition Bureau Looks For In White Papers
• Corporate Compliance Through The Lens Of Calif. Privacy Law
• 7th Circ. Affirms 5-Year Sentence For Chiropractor's Fraud
• GSK Calls For Preemption Ruling In Zofran Birth Defect MDL
• NY Court OKs Hospital's Trial Win In Patient Death Suit
• A Look At How States Are Experimenting With Health Care
• Q&A With Skadden Mass Torts Leader John Beisner
• 3 Cos. Raise $1B In IPOs Led By Peruvian Asset Manager
• 1st Circ. Takes A Bite Out Of Advertising Injury Coverage
• The Potential Effects Of Calif. Contractor Reclassification Bill
• State AGs Urge FDA To Keep Exploring Cannabis Regulation
• Texas Doc, Health Service Group Must Face Med Mal Suit
• Talc Left 'Fingerprint' In Ky. Travel Agent's Lungs, Jury Hears
• Pfizer Wants Breast Cancer Drug MDL Consolidated In Del.
• 2.2M Clinical Pathology Patients Added To AMCA Data Breach
• Jury Convicts Doctor, Nurse For $7.8M Health Care Fraud
• AIG Awarded Atty Fees After Harassment Suit Coverage Row
• SEC Slaps Former OSI Systems Exec With Insider Trading Suit
• CVS Says It's 'Impossible' To Tell Who's In Price-Gouging Suit
• Pfizer Hid Risks Of Sepsis, Amputation On Labels, Suit Says
• Real Estate Rumors: Magnum, Oscar Health, Trez Forman
• Remembering Justice Stevens As A Law Firm Leader
• 5 Cos. Price IPOs Totaling $1.1B, Led By Danish Biotech Firm
• DOJ Indicts Opioid Distributor, Execs Over Painkiller Sales
• Calif. Privacy Law's 3 Limited Exemptions For Health Cos.
• Martin Shkreli's Conviction Upheld By 2nd Circ.
• Ethicon Mesh Had Abysmal Success Rate, Surgeon Says
• Pa. Med Mal Insurer Law Won't Get Blocked, For Now
• 'May I Just Ask': Era Of Civility Passes With Justice Stevens
• Justice Stevens' Chevron Legacy Under Attack
• 3 Times Justice Stevens Boosted Privacy Rights
• 'Kindness, Humility, Wisdom': Justices Remember Stevens
• 6th Circ. Tosses Parents' Suit Over Merck's Gardasil
• The Stories They Tell About Justice Stevens
• Hear Justice Stevens In 5 Memorable Moments On The Bench
• 5 Times Justice Stevens Impacted Product Liability Law
• Justice Stevens' High Court Legacy In 4 Charts
• Express Scripts Can't Shake Pa. Records Fee Class Action
• FDA Must Hand Over Theranos Docs To Ex-CEO Holmes
• Muslim Woman Accuses NJ Hospital Of Religious Bias
• High Court Should Take ERISA Preemption Case, Insurers Say
• 4 Key Moments From J&J's Okla. Opioid Trial
• 6th Circ. Won't Give Doc Another Shot At NYT Defamation Suit
• Republicans Criticize Another Trump Judicial Nominee
• Health-Minded REIT Nabs $858M Share Sale For Hospital Buys
• No Need To Reopen 21st Century Ch. 11, Doctors Say
• Air Ambulance Co. Inks $3M Deal To Ground Overtime Suit
• 5 Takeaways From DOJ Focus On Chinese Trade Secret Theft
• Loestrin Buyers Win Cert. In Antitrust Battle With Pharmas
• Data Analytics Decision Highlights Product Liability Questions
• Attys Should Honor Their Word In Fee Split, Pa. Judge Says
• Nursing Home Mogul Esformes To Face Sentencing In Sept.
• Surgeon Tells Calif. Judge Women's Bodies Reject J&J Mesh
• Landscaping Co. To Pay $800K Over Doctor's Icy Fall
• Flawed Vetting Of Jurors Warrants Med Mal Retrial, Court Says
• A Look Back At Justice Stevens' Most Important Opinions
• Justice John Paul Stevens' Brand Of Judicial Humility
• GAO Rejects Protest Over VA Erectile Dysfunction Drug Deal
• Workers Sue Yale Over Wellness Program's Fines
• Retired Justice John Paul Stevens, Hero To Left, Dead At 99
• Philly Kids Hospital's Owner Proposes Fast Ch. 11 Sale Plan
• Insurer's Opioid Suit Not Rooted In Federal Law, Judge Says
• Drexel Says Insurer Must Pay For Sex Assault Claims Defense
• Panel Weighs Fla. House's Entry Into Medical Pot Law Case
• Loestrin Buyers Seek Approval Of $1M Lupin Deal
• Real Estate Rumors: Prime US REIT, Muss, InvenTrust
• Cannabis-Focused SPAC Prices $575M Canadian IPO
• No-Cost NJ Hospital Saves Cardiac-Patient Steering Claims
• Judge OKs Release Of National Opioid Sales Data
• Answers To Key Legal Finance Ethics Questions
• Pharmacy Benefit Cos. Improved Opioid Policies, Judge Says
• Former Insys Execs Want Sentencing Delayed Until 2020
• DOJ, CVS In 'Uncharted Territory' In Final Aetna Deal Fight
• Tips For Avoiding Multistate HIPAA Data Breach Lawsuits
• J&J Can't Quit Deception Playbook, Okla. Says In Closings
• Reckitt Hit With Stock Drop Suit Over $1.4B Opioid Probe Deal
• J&J Hid Painful Mesh Problems, Calif. Says At Trial's Start
• LabMD's Bid For Tiversa Records Shot Down As 'Overreach'
• WinCo Partially Escapes Dialysis Benefit Suit
• Jackson Lewis Lures Benefits, Labor Pros In Calif.
• Pa. Says Ch. 11 Hospital License Sale Needs State Approval
• Fla. Court Says Elder Abuse Claim Can't Be Med Mal
• 11th Circ. Won't Stick Oxford With Fees In Benefits Suit
• CVS-Aetna Challengers Push Back On Exec's PBM Claims
• Federal Agencies Need A Uniform Record-Keeping Process
• Biden Unveils Plan To Strengthen ACA Tax Credits
• E-Prescription Co. Hopes To Zap FTC Monopoly Case
• New HRA Regulations Are Welcome, But Watch For Pitfalls
• Feds Press To End Whistleblower Suit Over Tribal Firing
• 2 Health-Focused Businesses Aim For IPOs Totaling $280M
• Insys Proposes Novel Gov't Committee Deal In Ch. 11 Case
• USPTO Guidance Changes Cannabis TM Filing Strategy
• NFL Health Plan, Cigna Units Look To Spike ERISA Suit
• Breaking Down J&J And California's $1B Pelvic Mesh Trial
• Philly Hospital's $65M DIP Loan Approved After Roll-Up Tweak
• 3rd Circ. Backs Temporary Halt Of Trump Birth Control Rules
• J&J Again Asks For Win As Okla. Opioid Trial Testimony Ends
• How A Doc's FCA Suit Turned Into $1.4B Opioid Deal
• Personal Injury And Med Mal Cases To Watch: Midyear Report
• Native American Cases To Watch In 2nd Half Of 2019
• SF Nurses Get Conditional Cert. In OT Collective Action
• Baker Botts, Goodwin Steer $429M In Solar, Health Care IPOs
• Pa. Justices Snub Appeal In Nursing Home Arbitration Row
• Dentists Worry FCC Robocall Rules Will Curb Patient Outreach
• Dental Supplier Says 2nd Circ. Sunk Startup's Damages Claim
• ERISA Doesn't Apply To Hospital Bill Suit, 6th Circ. Says
• J&J Surgical Staplers Injured Man's Stomach, Suit Claims
• Taxation With Representation: Skadden, Sullivan, Wachtell
• The Role Of Dictionaries In Last Term's High Court Decisions
• UnitedHealthcare Hit With Substance Use Coverage Suit
• How To Evaluate The Rise In Legal Employment
• Abortion Referral 'Gag Rule' Survives Full 9th Circ., For Now
• J&J Opioids Were Sliver Of The Okla. Market, Judge Told
• Fed. Circ. Unsure If PTAB Has To Explain Axing Avastin Patent
• 7th Circ. Digs Into Injunction Over Ind. Abortion Clinic License
• The 6 Biggest Cybersecurity Episodes So Far In 2019
• ACA Case Places Age-Old Legal Doctrine In Spotlight
• Philly Hospital's Ch. 11 Closure Hearing Pushed By Del. Judge
• Loestrin Buyers Fight To Advance Antitrust Case To Trial
• Couple Sues Fertility Center For Implanting Wrong Embryos
• Eli Lilly Searches For New GC As Top Atty Plans To Retire
• Premera Blue Cross To Pay States $10M To End Breach Probe
• Indiana AG Says Medical Debt Collector Belongs In Ch. 7
• Mass. Top Court Expands Hearsay Rule In Civil Cases
• Reckitt To Pay $1.4B To End US Opioid Probe
• Ex-Puerto Rico Officials Charged In $15.5M Contracts Scheme
• Opioid Crisis Not Ex-J&J Subsidiary's Fault, Exec Testifies
• Texas Doctor Beats Med Mal Suit On Bad Expert Report
• New Trial Upheld For J&J After $417M Talc Verdict
• Morgan Lewis Settles $30M Pa. Suit Over Alleged Conflict
• Rite Aid Can't Arbitrate Generics Price Suit, Shopper Says
• Heritage Says Conn. Leaked Email About Congressional Probe
• Insys May Face Restitution Above $30M Penalty For Kickbacks
• GSK Gets 2nd Chance To Argue Preemption In Zofran MDL
• 3 Takeaways From Nixing Of Drug Pricing Rule
• Pa. Ambulance Co. Inks Deal To End Medicare Fraud Claims
• Bankrupt Philadelphia Hospital Floats Resident Program Sale
• How High Court FOIA Ruling Will Help Gov't Contractors
• Cozen O'Connor DQ'd Over Client Conflict In Cannabis Deal
• 3M Says Patient Attys' Sanctions Bid Over Docs Retaliatory
• 5th Circ. Judges Question If ACA Can Stand Without Mandate
• Okla. Says J&J Addiction Expert Is Just A 'Book Reviewer'
• Fla. Medical Marijuana Statute Deemed Unconstitutional
• ND Med Merger Fight Dropped After 8th Circ. Ruling
• BioScrip Investor Wants Option Care Merger Vote Halted
• Home Care Group Fights Calif. Union Contact Disclosure Law
• Ex-M&A Firm Employee Pleads Guilty To Stealing Funds
• The Business Case For Championing Diverse Legal Teams
• Can Data Solve BigLaw's Diversity Problems?
• 12 Attorneys On How Diversity Gives Them The Edge
• Ex-CCO Says She Was Fired For Blowing Whistle On Boss
• Nursing Home Operator Owes $2M To Brain Clinic: 7th Circ.
• ARIA Paves The Way For US Reengagement With Asia
• UnitedHealthcare Says Prostate Cancer Treatment Suit Flawed
• Feds, Alaska Tribal Health Co. Reach Deal In Funding Suit
• Ex-Laser Surgery Chain Workers Win Cert. In Layoffs Suit
• PE Firm Prospect Hill Closes 2nd Fund At $380M
• Mass. Court Reminds Employers Of FMLA Due Diligence
• J&J Loses Bid To Escape Okla.'s Opioid Megatrial
• NY Hospital Can Shield Internal Records In Baby Injury Suit
• How The Legal Pipeline Is Failing Black Attorneys
• WADA Joins Europol In Massive Crackdown On Steroids
• Ex-Hospice Aide Says Settlement Ended Records Theft Case
• UK Opens Competition Probe Into Health Care Sector Conduct
• Judge Nixes Rule Forcing Drug Prices In TV Ads
• Ill. Court Affirms $4.8M Med Mal Award In Patient Death Suit
• In Their Own Words: 9 Partners On Diversity At Work
• The Best Firms For Minority Equity Partners
• Ex-Insys Bosses Still Aiding 8 Kickback Probes, Feds Say
• Dad Fights Oxford's Bid To Nix Suit Over Son's Benefits Denial
• The Art Of The 'Science And Expert Team' In Mass Torts
• Biggest Merger Reviews Of 2019: Midyear Report
• Attys Seek $7.8M For $24M Deal In Anthem 401(k) Suit
• Akorn Investors Seek Cert. In Suit Over Failed Merger
• Key Contractor Might Cut Off Philly Hospital In Ch. 11
• Ex-NYU Prof Fired For 'Bizarre' Email Conduct, School Says
• Misconceptions In The Debate About Noncompetes
• Kirkland Assists As Flexpoint Collects $2B Total For Funds
• Law360's Diversity Snapshot By The Numbers
• Diversity Efforts At Many Firms Ignore Disabled Attorneys
• The Best Firms For Minority Attorneys
• Despite Progress, Firms Still Slow To Track LGBT Data
• J&J Cash Can't Sway Medicine's High Priests, Surgeon Says
• Okla. Opioid Case 'Should End Here And Now,' J&J Says
• Hospital Says Former Rival Can't Alter Antitrust Suit After Sale
• 1st Circ. Brushes Off Dental Co.'s Insurance Claim For TM Suit
• Calif. Co. Can't Block 'Grisly' Anti-Abortion Protest Pics
• SC Physician Preserves Trial Win In Birth Injury Suit
• Meet The 5th Circ. Judges Weighing The ACA's Future
• Cancer Center Asks To Reopen Ch. 11 To End Antitrust Suit
• Health Hires: Carlson & Jayakumar, Baker Donelson, Ropes
• Next Supreme Court Term Already Filled With Headliners
• 9th Circ. Seeks Nevada's Help With Defense Recoup Riddle
• Trans Professor Wants Title VII Sex Bias Claim Kept Alive
• Prison Health Contractor Shorted Therapists' OT, Suit Says
• The Top Injury And Med Mal Cases Of 2019: Midyear Report
• The Top Antitrust Conduct Cases Of 2019: Midyear Report
• J&J Opioid Sales Rep Wooed 'Pill Mill' Doctors, Judge Hears
• Md. Jury Awards Whopping $229M In Birth Injury Suit
• Union Asks To Yank NLRB Charge That Caught GC's Eye
• Tiversa Wants LabMD Sanctioned Over Deposition Questions
• 4th Circ. Lifts Ban On Abortion 'Gag Rule'
• Feds, Drugmakers Grilled Over Rule Mandating Prices In Ads
• Insys Reaches Ch. 11 Deal To Pause State Opioid Suits
• NJ To Phase Out Sales Tax On Medical Pot, Allow Local Tax
• Sens. Probe Tax-Exempt Medical Groups' Ties To Drugmakers
• Doctor Training Programs Spark Fight In Philly Hospital Ch. 11
• Aviacode To Pay Coders Over $1.5M To End Wage Suit
• Esformes Can't Get Forfeiture Verdicts Tossed
• DaVita Workers Missed Chance At OT Suits, 10th Circ. Says
• 2nd Circ. Sends Home Care Worker's Wage Suit To Arbitration
• Trans Librarian Seeks Quick Win In Alaska Surgery Bias Suit
• Rethinking The Tech-First Approach To Law Firm Solutions
• Limits Of DOJ's Qui Tam Dismissal Authority Are Unsettled
• Inovia Leads $25M Fundraise For Health Tech Biz AlayaCare
• Davis Polk Assists On RoundTable's $700M Health Care Fund
• J&J's Addiction Expert Slammed For Touting Screening Tools
• Drug Return Co. Must Pay $94M Restitution In Fraud Case
• Pharmacy, PE Fund Near Deal To End Feds' FCA Kickback Suit
• NJ, Pa. Slam Trump Admin. Birth Control Exemptions To ACA
• Opioid MDL Litigants Seek Triumphs Before Bellwether Trial
• Calif. Hospital Keeps Win In Suit Over Childbirth Injuries
• Maryland Hospital Co. Settles EEOC Disability Bias Charge
• HHS Postpones Worker 'Conscience' Rule For Abortions
• States Want In On CVS-Aetna Hearing To Back DOJ
• No Prison For Ex-Penn Coach Who Helped Convict Esformes
• Virtua Acquires Lourdes Health System In NJ
• Partners Uses Old Mortality Rates For Annuities, Suit Says
• How Opioid 'Negotiating Class' Would Affect Civil Claims
• Philly Hospitals Hit Ch. 11 After Announcing Facility Closure
• How Pa. High Court Ruling Makes Life Easier For Corp. Clients